Mastering complex TAVI: achieving optimal outcomes with Evolut FX+

Sponsored by Medtronic

Anchorperson: D. Mylotte

Spokesperson: F. Sawaya

Summary

This EuroPCR 2026 session focuses on advancing the management of complex transcatheter aortic valve implantation (TAVI) procedures using Evolut FX+ technology.

It highlights the benefits of supra-annular TAVI in patients with severe bicuspid aortic stenosis, supported by a review of available clinical evidence.

Through a series of case-based discussions, the programme explores practical approaches to challenging scenarios, including TAV-in-SAV and TAV-in-TAV interventions, with emphasis on procedural planning and technical execution.

The session also reviews recent technological developments that are expanding the feasibility of treating complex aortic anatomies, illustrating how evolving device design can support optimal procedural outcomes.

Learning Objectives

To appreciate the advantages of supra-annular TAVI in patients with severe bicuspid aortic valve stenosis - With a review of supporting clinical data
To learn how to perform TAV-in-SAV and TAV-in-TAV procedures
To discern the latest technological evolutions that enable the treatment of patients with complex anatomy